주식회사 인트로바이오파마

{
  "address": "경기도 평택시",
  "ceo_name": "박석용",
  "certificate": [
    {
      "cert_number": "20140104993",
      "changes": "",
      "disclosure_date": "2014-04-25",
      "first_cert_date": "2014-04-25",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-04-25 ~ 2016-04-24"
    },
    {
      "cert_number": "20160105976",
      "changes": "",
      "disclosure_date": "2016-05-20",
      "first_cert_date": "2014-04-25",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-04-25 ~ 2018-04-24"
    },
    {
      "cert_number": "20180105706",
      "changes": "",
      "disclosure_date": "2018-05-15",
      "first_cert_date": "2014-04-25",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-04-25 ~ 2020-04-24"
    },
    {
      "cert_number": "20200109229",
      "changes": "",
      "disclosure_date": "2020-07-08",
      "first_cert_date": "2014-04-25",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-07-08 ~ 2022-07-07"
    },
    {
      "cert_number": "20220720020022",
      "changes": "",
      "disclosure_date": "2022-07-20",
      "first_cert_date": "2014-04-25",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2022-07-08 ~ 2025-07-07"
    },
    {
      "cert_number": "20250717020013",
      "changes": "",
      "disclosure_date": "2025-07-17",
      "first_cert_date": "2014-04-25",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2025-07-08 ~ 2028-07-07"
    }
  ],
  "company_name": "주식회사 인트로바이오파마",
  "corp_no": "131411-*******",
  "financials": {
    "2022": {
      "capital_stock": 75230000,
      "cost_of_sales": 11339190000,
      "current_assets": 7727125000,
      "current_liabilities": 4446971000,
      "gross_profit": 4811273000,
      "net_income": 662092000,
      "net_income_bs": 640142000,
      "non_current_assets": 5547111000,
      "non_current_liabilities": 1694693000,
      "non_operating_expenses": 150912000,
      "non_operating_income": 179238000,
      "operating_profit": 633766000,
      "revenue": 16150463000,
      "sga_expenses": 4177507000,
      "total_assets": 13274236000,
      "total_equity": 7132572000,
      "total_liabilities": 6141664000
    },
    "2023": {
      "capital_stock": 75229000,
      "cost_of_sales": 12274549000,
      "current_assets": 7967097000,
      "current_liabilities": 6893913000,
      "gross_profit": 2895638000,
      "net_income": 1279536000,
      "net_income_bs": 1507263000,
      "non_current_assets": 7080027000,
      "non_current_liabilities": 24763000,
      "non_operating_expenses": 142661000,
      "non_operating_income": 227943000,
      "operating_profit": 1194254000,
      "revenue": 15170187000,
      "sga_expenses": 1701384000,
      "total_assets": 15047124000,
      "total_equity": 8128448000,
      "total_liabilities": 6918676000
    },
    "2024": {
      "capital_stock": 75229000,
      "cost_of_sales": 12196993000,
      "current_assets": 6692007000,
      "current_liabilities": 3953750000,
      "gross_profit": 3567357000,
      "net_income": 1522508000,
      "net_income_bs": 1320767000,
      "non_current_assets": 6945938000,
      "non_current_liabilities": 8347000,
      "non_operating_expenses": 224741000,
      "non_operating_income": 216278000,
      "operating_profit": 1530971000,
      "revenue": 15764350000,
      "sga_expenses": 2036386000,
      "total_assets": 13637945000,
      "total_equity": 9675848000,
      "total_liabilities": 3962097000
    }
  },
  "industry": "합성의약품 및 기타 완제 의약품 제조업",
  "investment": [],
  "main_products": "오큐베리정 위드풀과립 뉴로시드정 등",
  "phone": "031-647-****",
  "years": [
    2024,
    2023,
    2022
  ]
}